van Linde ME, Labots M, Brahm CG, Hovinga KE, et al. Tumor drug concentration and phosphoproteomic profiles after two weeks of treatment with sunitinib in patients with newly-diagnosed glioblastoma. Clin Cancer Res 2022 Feb 14. pii: 681709. doi: 10.1158/1078-0432.CCR-21-1933.
PMID: 35191463